ABSTRACT
Background Global targets to reduce salt intake have been proposed but their monitoring is challenged by the lack of population-based data on salt consumption. We developed a machine learning (ML) model to predict salt consumption based on simple predictors, and applied this model to national surveys in low- and middle-income countries (LMICs).
Methods Pooled analysis of WHO STEPS surveys. We used 19 surveys with spot urine samples for the ML model derivation and validation; we developed a supervised ML regression model based on: sex, age, weight, height, systolic and diastolic blood pressure. We applied the ML model to 49 new STEPS surveys to quantify the mean salt consumption in the population.
Results The pooled dataset in which we developed the ML model included 45,152 people. Overall, there were no substantial differences between the observed (8.1 g/day (95% CI: 8.0-8.2 g/day)) and ML-predicted (8.1 g/day (95% CI: 8.1-8.2 g/day)) mean salt intake (p= 0.065). The pooled dataset where we applied the ML model included 157,699 people; the overall predicted mean salt consumption was 8.1 g/day (95% CI: 8.1-8.2 g/day). The countries with the highest predicted mean salt intake were in Western Pacific. The lowest predicted intake was found in Africa. The country-specific predicted mean salt intake was within reasonable difference from the best available evidence.
Conclusions A ML model based on readily available predictors estimated daily salt consumption with good accuracy. This model could be used to predict mean salt consumption in the general population where urine samples are not available.
Funding Wellcome Trust (214185/Z/18/Z)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RMC-L is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We did not seek approval by an Institutional Review Board. We used individual-level survey data which do not include any personal identifiers.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
This study used nationally-representative survey data that are in the public domain, which was requested through the online repository (https://extranet.who.int/ncdsmicrodata/index.php/home). We provide the analysis code of data preparation and data analysis as supplementary materials to this paper.
